Regulators last year approved a first-of-its-kind jab to protect against respiratory syncytial virus, responsible for nearly 50,000 hospitalisations every year and linked to about 8,000 deaths. Regulators last year approved a first-of-its-kind jab to protect against respiratory syncytial virus, responsible for nearly 50,000 hospitalisations every year and linked to about 8,000 deaths.
Campaigners’ outrage over ‘deeply cynical’ decision to exclude over-80s from potentially life-saving vaccine rollout
